Search Results - "VAN DER VOORT, Robbert"

Refine Results
  1. 1

    Coinhibitory molecules in hematologic malignancies: targets for therapeutic intervention by Norde, Wieger J., Hobo, Willemijn, van der Voort, Robbert, Dolstra, Harry

    Published in Blood (26-07-2012)
    “…The adaptive immune system can be a potent defense mechanism against cancer; however, it is often hampered by immune suppressive mechanisms in the tumor…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Nanomedicine in cancer therapy: promises and hurdles of polymeric nanoparticles by Paus, Carmen, van der Voort, Robbert, Cambi, Alessandra

    Published in Exploration of medicine (30-04-2021)
    “…The limitations of current cancer treatments have stimulated the application of nanotechnology to develop more effective and safer cancer therapies. Remarkable…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Expression of c-Met and Heparan-Sulfate Proteoglycan Forms of CD44 in Colorectal Cancer by Wielenga, Vera J.M., van der Voort, Robbert, Taher, Taher E.I., Smit, Lia, Beuling, Esther A., van Krimpen, Cees, Spaargaren, Marcel, Pals, Steven T.

    Published in The American journal of pathology (01-11-2000)
    “…In colorectal cancer patients, prognosis is not determined by the primary tumor but by the formation of distant metastases. Molecules that have been implicated…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Paracrine regulation of germinal center B cell adhesion through the c-met-hepatocyte growth factor/scatter factor pathway by van der Voort, R, Taher, T E, Keehnen, R M, Smit, L, Groenink, M, Pals, S T

    Published in The Journal of experimental medicine (16-06-1997)
    “…T cell-dependent humoral immune responses are initiated by the activation of naive B cells in the T cell areas of the secondary lymphoid tissues. This primary…”
    Get full text
    Journal Article
  8. 8

    In situ tumor ablation creates an antigen source for the generation of antitumor immunity by BROK, Martijn H. M. G. M. Den, SUTMULLER, Roger P. M, VAN DER VOORT, Robbert, BENNINK, Erik J, FIGDOR, Carl G, RUERS, Theo J. M, ADEMA, Gosse J

    Published in Cancer research (Chicago, Ill.) (01-06-2004)
    “…Tumor-destructing techniques, like radiofrequency ablation (RFA), allow eradication of large tumors. Potentially, in situ tumor destruction also can provide…”
    Get full text
    Journal Article
  9. 9

    Novel insights in the regulation of CCL18 secretion by monocytes and dendritic cells via cytokines, toll-like receptors and rheumatoid synovial fluid by van Lieshout, Antoine W T, van der Voort, Robbert, le Blanc, Linda M P, Roelofs, Mieke F, Schreurs, B Willem, van Riel, Piet L C M, Adema, Gosse J, Radstake, Timothy R D J

    Published in BMC immunology (19-09-2006)
    “…The T cell attracting chemokine CCL18 is produced by antigen presenting cells and a role for CCL18 has been suggested in the pathogenesis of a variety of…”
    Get full text
    Journal Article
  10. 10
  11. 11

    An alternatively spliced CXCL16 isoform expressed by dendritic cells is a secreted chemoattractant for CXCR6+ cells by Voort, Robbert, Verweij, Viviènne, Witte, Theo M., Lasonder, Edwin, Adema, Gosse J., Dolstra, Harry

    Published in Journal of leukocyte biology (01-06-2010)
    “…A secreted isoform of the chemokine CXCL16 contributes to the interaction between dendritic cells and CXCR6+ lymphocytes. DC are professional APCs that…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Heparan Sulfate-modified CD44 Promotes Hepatocyte Growth Factor/Scatter Factor-induced Signal Transduction through the Receptor Tyrosine Kinase c-Met by van der Voort, R, Taher, T E, Wielenga, V J, Spaargaren, M, Prevo, R, Smit, L, David, G, Hartmann, G, Gherardi, E, Pals, S T

    Published in The Journal of biological chemistry (05-03-1999)
    “…CD44 has been implicated in tumor progression and metastasis, but the mechanism(s) involved is as yet poorly understood. Recent studies have shown that CD44…”
    Get full text
    Journal Article
  14. 14

    Analysis of dendritic cell trafficking using EGFP-transgenic mice by Eggert, Andreas A.O., van der Voort, Robbert, Torensma, Ruurd, Moulin, Veronique, Boerman, Otto C., Oyen, Wim J.G., Punt, C.J.A., Diepstra, Heleen, de Boer, Annemiek J., Figdor, Carl G., Adema, Gosse J.

    Published in Immunology letters (09-10-2003)
    “…Dendritic cells (DCs) are professional antigen presenting cells, well equipped to initiate an immune response. For effective induction of an immune response,…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    siRNA silencing of PD-L1 and PD-L2 on dendritic cells augments expansion and function of minor histocompatibility antigen–specific CD8+ T cells by Hobo, Willemijn, Maas, Frans, Adisty, Niken, de Witte, Theo, Schaap, Nicolaas, van der Voort, Robbert, Dolstra, Harry

    Published in Blood (25-11-2010)
    “…Tumor relapse after human leukocyte antigen–matched allogeneic stem cell transplantation (SCT) remains a serious problem, despite the long-term presence of…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy by van der Waart, Anniek B., Noortje van de Weem, M.P., Maas, Frans, Kramer, Cynthia S.M., Michel Kester, G.D., Frederik Falkenburg, J.H., Schaap, Nicolaas, Jansen, Joop H., van der Voort, Robbert, Gattinoni, Luca, Hobo, Willemijn, Dolstra, Harry

    Published in Blood (27-11-2014)
    “…Effective T-cell therapy against cancer is dependent on the formation of long-lived, stem cell–like T cells with the ability to self-renew and differentiate…”
    Get full text
    Journal Article
  20. 20